Results 11 to 20 of about 6,825 (177)

Precision medicine in pantothenate kinase-associated neurodegeneration

open access: yesNeural Regeneration Research, 2019
Neurodegeneration with brain iron accumulation is a broad term that describes a heterogeneous group of progressive and invalidating neurologic disorders in which iron deposits in certain brain areas, mainly the basal ganglia.
Mónica Alvarez-Cordoba   +8 more
doaj   +5 more sources

Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration [PDF]

open access: yesJournal of Experimental Neuroscience, 2019
Multiple approaches to therapy have been proposed for the rare inherited neurodegenerative disease associated with mutations in the PANK2 gene, called pantothenate-kinase-associated neurodegeneration (PKAN).
Suzanne Jackowski
doaj   +4 more sources

Pantothenate kinase-associated neurodegeneration [PDF]

open access: yesKoc D: Pantothenate kinase-associated neurodegeneration, 2020
Neurodegeneration with brain iron accumulation is a group of disorders, the commonest of which is PKAN (Pantothenate kinase associated neurodegeneration).
Sandra M.H. Nordlie   +3 more
core   +7 more sources

Human pantothenate kinase 4 is a pseudo‐pantothenate kinase [PDF]

open access: yesProtein Science, 2019
AbstractPantothenate kinase generates 4′‐phosphopantothenate in the first and rate‐determining step of coenzyme A (CoA) biosynthesis. The human genome encodes three well‐characterized and nearly identical pantothenate kinases (PANK1‐3) plus a putative bifunctional protein (PANK4) with a predicted amino‐terminal pantothenate kinase domain fused to a ...
Jiangwei Yao   +2 more
exaly   +5 more sources

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration [PDF]

open access: yesJournal of Movement Disorders, 2009
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder that is characterized by mutations in the pantothenate kinase 2 gene (PANK2) and typical magnetic resonance imaging findings.
Sung-Hyouk Kim   +6 more
doaj   +2 more sources

Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models. [PDF]

open access: yesPLoS ONE, 2018
In cells, phosphorylation of pantothenic acid to generate phosphopantothenic acid by the pantothenate kinase enzymes is the first step in coenzyme A synthesis.
Daniel Elbaum   +7 more
doaj   +2 more sources

Novel PANK2 mutation in the first Greek compound heterozygote patient with pantothenate-kinase-associated neurodegeneration

open access: yesSAGE Open Medical Case Reports, 2017
Pantothenate-kinase-associated neurodegeneration is the most common autosomal recessive form of neurodegeneration with brain iron accumulation. Less than 100 mutations in PANK2 gene (20p13) are responsible for classic and atypical cases.
George P Paraskevas   +6 more
doaj   +4 more sources

Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues. [PDF]

open access: yesPLoS Pathogens, 2018
The malaria-causing blood stage of Plasmodium falciparum requires extracellular pantothenate for proliferation. The parasite converts pantothenate into coenzyme A (CoA) via five enzymes, the first being a pantothenate kinase (PfPanK).
Erick T Tjhin   +13 more
doaj   +2 more sources

Pantothenate kinase-associated neurodegeneration (Hallerworden–Spatze disease): clinical aspects, diagnosis, treatment (literature review and own data)

open access: yesZaporožskij Medicinskij Žurnal, 2021
Aim. To analyze current data of scientific literature on the etiology, pathogenesis, approaches to the diagnosis and treatment of rare orphan disease – pantothenate kinase-associated neurodegeneration and to describe the clinical case of this disease.
Yu. H. Antypkin   +6 more
doaj   +3 more sources

Acanthocytes in Pantothenate Kinase Associated Neurodegeneration

open access: yes, 2006
Hallervorden-Spatz syndrome (HSS) and HARP syndrome (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration) were shown to be due to mutations in the gene for pantothenate kinase 2 (PANK2). It was suggested that this group of disorders should now be referred to as pantothenate kinase associated neurodegeneration ...
Klopstock T., Elstner M., Malandrini A.
openaire   +4 more sources

Home - About - Disclaimer - Privacy